Predict your next investment

Sofie Biosciences company logo
Corporation
HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
sofie.com

See what CB Insights has to offer

Stage

Acquired - II

Total Raised

$16.65M

Investors Count

6

Deal Terms

2

Portfolio Exits

1

Sofie Biosciences Funding, Sofie Biosciences Valuation & Sofie Biosciences Revenue

7 Fundings

Sofie Biosciences's latest funding round was a Loan for $3.5M on April 6, 2020.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/6/2020

Loan

$3.5M

$0.00B

((9.99x))

FY 1234

3/5/2020

Series C

$99M

$0.00B

((9.99x))

FY 1234

10

7/29/2019

Unattributed

$99M

$0.00B

((9.99x))

FY 1234

10

6/13/2016

Series B

$99M

$0.00B

((9.99x))

FY 1234

10

10/16/2014

Grant

$99M

$0.00B

((9.99x))

FY 1234

10

Date

4/6/2020

3/5/2020

7/29/2019

6/13/2016

10/16/2014

Round

Loan

Series C

Unattributed

Series B

Grant

Amount

$3.5M

$99M

$99M

$99M

$99M

Investors

Valuation

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

10

10

10

10

Sofie Biosciences Deal Terms

2 Deal Terms

Sofie Biosciences's deal structure is available for 2 funding rounds, including their Series B from June 13, 2016.

Round

Series B

Series A

Funding Date

$99M

Pre-Money Valuation

Post-Money Valuation

Amount Raised

$99M

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$99M

Board Voting

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series B

$99M

$99M

$99M

$99M

Series A

Sofie Biosciences Investors

6 Investors

Sofie Biosciences has 6 investors. Paycheck Protection Program invested in Sofie Biosciences's Loan funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

4/6/2020

4/6/2020

1
Loan

Government

DC

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Government

Maryland

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

California

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Corporation

India

First funding

4/6/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Last Funding

4/6/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Rounds

1
Loan

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Board Seats

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Type

Government

Venture Capital

Government

Venture Capital

Corporation

Location

DC

California

Maryland

California

India

Sofie Biosciences Acquisitions

1 Acquisition

Sofie Biosciences acquired 1 company. Their latest acquisition was Zevacor Pharma on May 11, 2017.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

5/11/2017

Acquired

Acquired

1

Date

5/11/2017

Investment Stage

Acquired

Companies

Valuation

Total Funding

Note

Acquired

Sources

1

Sofie Biosciences Portfolio Exits

1 Portfolio Exit

Sofie Biosciences has 1 portfolio exit. Their latest portfolio exit was Zevacor Pharma on March 03, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

3/3/2020

Acquired - II

1

Date

3/3/2020

Exit

Acquired - II

Companies

Valuation

Acquirer

Sources

1

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.